![]() | GEORGE LEE IrvinDivision of Endocrine Surgery, University of Miami Health System, University of Miami Leonard M. Miller School of Medicine, Miami, FL | Medical University of South Carolina, ... |
KOL Resume for GEORGE LEE Irvin
Year | |
---|---|
2011 | Division of Endocrine Surgery, University of Miami Health System, University of Miami Leonard M. Miller School of Medicine, Miami, FL |
2010 | Medical University of South Carolina, Charleston, SC |
2009 | DeWitt Daughtry Family Department of Surgery, Division of Endocrine Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, FL |
2008 | Division of Endocrine Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida (Drs Solorzano, Mendez, Lew, Rodgers, and Irvin and Ms Montano) DeWitt Daughtry Family Department of Surgery, University of Miami, Miami, Fla |
2007 | Department of Surgery, Medical University of South Carolina, Charleston, South Carolina and University of Miami Miller School of Medicine, Florida, Miami, Fla Division of Endocrine Surgery, University of Miami Miller School of Medicine, 1475 NW 12th Ave, Room 3550, 33136, Miami, FL, USA |
2006 | Departments of Surgery, Miller School of Medicine, University of Miami, Miami, FL |
2005 | DeWitt Daughtry Family Department of Surgery, University of Miami/Jackson Memorial Medical Centers and the Sylvester Cancer Center, Miami, FL. Assistant Professor of Surgery, University of California, San Francisco/Mt. Zion Medical Center, San Francisco, California |
2004 | DeWitt Daughtry Family Department of Surgery, University of Miami School of Medicine, Miami, FL Sylvester Comprehensive Cancer Center, 1475 NW 12 Avenue, Room 3524, 33136, Miami, Florida, USA |
2003 | From the DeWitt Daughtry Family Department of Surgery, University of Miami/Jackson Memorial, the Department of Veteran Affairs Medical Centers, and the Sylvester Comprehensive Cancer Center, Miami, Fla, USA |
2002 | From the Department of Surgery, University of Miami/Jackson Memorial, and Department of Veteran Affairs Medical Centers, Miami, Florida; and Mount Sinai School of Medicine, New York, NY Miami, Fla |
2001 | From the Daughtry Family Department of Surgery, University of Miami School of Medicine, Jackson Memorial and Veterans Affairs Medical Centers, and the Sylvester Comprehensive Cancer Center, Miami, Florida |
2000 | Department of Surgery, Jackson Memorial Hospital, University of Miami, PO Box 016310 (M-875), Miami, FL 33101, USA. |
1999 | Department of Surgery, University of Miami School of Medicine, Miami, FL. USA From the University of Miami School of Medicine, Miami, Fla |
1996 | Veterans Affairs Medical Center, Miami, Fla, USA |
1994 | Department of Surgery, University of Miami Miami, Florida |
1993 | Department of Surgery, University of Miami School of Medicine, Fla. |
1991 | From the Department of Surgery, University of Miami School of Medicine, Jackson Memorial and Veterans Affairs Medical Centers, Miami, Florida USA |
1989 | Departments of Surgery, Medicine, and Anesthesiology, University of Miami School of Medicine, and the Veterans Administration Medical Center, Miami, Florida |
1988 | Research Service, Veterans Administration Medical Center, Miami, FL 33125. Department of Surgery, University of Miami School of Medicine, Fla. 33101. |
1987 | Department of Surgery, University of Miami School of Medicine, FL 33101. |
1986 | Research Service Veterans Administration Medical Center and Departments of Surgery, Urology, and Microbiology University of Miami School of Medicine Miami, Florida 33125 |
1985 | Department of Surgery, University of Miami School of Medicine, Miami, Florida 33125 |
1984 | From the Research Service of the Veterans Administration Medical Center and the Departments of Surgery, Urology and Microbiology of the University of Miami School of Medicine, Miami, Florida |
1982 | Veterans Administration Medical Center, and the Departments of Surgery and Urology, University of Miami School of Medicine, Miami, Florida |
1981 | Surgical Service, Veterans Administration Medical Center, Miami, and the Departments of Surgery, Urology, and Pathology, University of Miami School of Medicine |
1980 | Surgical Immunology Laboratory, Veterans Administration Hospital and the Departments of Microbiology and Surgery, University of Miami School of Medicine, Miami, Florida |
1979 | Miami, Florida USA |
1976 | From the Veterans Administration Hospital, and The Department of Surgery University of Miami School of Medicine Miami, Florida |
1974 | Division of Infectious Diseases, Department of Medicine, and Department of Surgery, University of Miami School of Medicine, and Veterans Administration Hospital, Miami, Florida 33125 |
1973 | Department of Surgery, University of Miami School of Medicine, and Veterans Administration Hospital, Miami, Florida 83125 |
1970 | Department of Surgery University of Miami School of Medicine Miami, Florida 33124, and The Veterans' Administration Hospital Miami, Florida 33125 |
1966 | Surgery Branch, National Cancer Institute, National Isstitutes of Health, Department of Health, Education, and Welfare, Bethestla, Martland 20014 |
1963 | Department of Surgery, University of North Carolina School of Medicine and the North Carolina Memorial Hospital, Chapel Hill, North Carolina |
GEORGE LEE Irvin: Influence Statistics
Concept | World rank |
---|---|
npe recurrence | #1 |
sphpt mgd | #1 |
remaining parathyroids | #1 |
failure multiglandular disease | #1 |
quantitative parathyroidectomy | #1 |
factors npe | #1 |
mild hpt parathyroidectomy | #1 |
samples parathyroidectomy | #1 |
localization operative | #1 |
postoperative npe patients | #1 |
specificity qpth | #1 |
parathyroidectomy operative time | #1 |
death prepared patients | #1 |
fihpt limited parathyroidectomy | #1 |
gland excision patients | #1 |
patients focused parathyroidectomy | #1 |
qpth specificity accuracy | #1 |
pth quick test | #1 |
publication primary monitoring | #1 |
pth npe | #1 |
assay qpth | #1 |
qpth parathyroidectomy | #1 |
mgd operative | #1 |
postoperative npe | #1 |
excision predict | #1 |
qpth miami criterion | #1 |
exploration excision | #1 |
surgical adjunct | #1 |
5 published criteria | #1 |
1 gland | #1 |
patients 10year outcome | #1 |
singlegland excision | #1 |
postoperative calcium levels | #1 |
hyperfunctioning tissue | #1 |
late parathyroid | #1 |
glands quick | #1 |
exploration quick | #1 |
parathormone elevation | #1 |
qpth guided | #1 |
intraoperative hormone | #1 |
qpth localization | #1 |
immunoassay intraoperative | #1 |
glands excised | #1 |
pth qpth | #1 |
Open the FULL List in Excel | |
Prominent publications by GEORGE LEE Irvin
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate?
[ PUBLICATION ]
BACKGROUND: The quick parathyroid hormone assay (QPTH) reliably measures intact parathyroid hormone (iPTH) levels intraoperatively. The accuracy in predicting postoperative calcemia is related to blood sample timing and the criteria applied. To improve specificity or to decrease the cost of QPTH, several criteria have been used to predict complete excision. This study compares the Miami criterion with other published QPTH criteria in predicting operative outcome.
METHODS: QPTH and the ...
Known for Intraoperative Ipth | Miami Criterion | Postoperative Calcium Levels | Tests Reproducibility | Complete Excision |
Consequences of Targeted Parathyroidectomy Guided by Localization Studies Without Intraoperative Parathyroid Hormone Monitoring
[ PUBLICATION ]
BACKGROUND: After excision of an abnormal gland, the dynamics of intraoperative parathyroid hormone (PTH) levels signal whether or not more hypersecreting tissue is present. This quantitative assurance of operative success has led to targeted exploration of the hyperfunctioning gland(s). Some have questioned the need for intraoperative PTH monitoring (IPM) in the presence of positive nuclear scanning. The purpose of this study was to examine the accuracy of nuclear scans in correctly ...
Known for Localization Studies | Parathyroid Hormone | Operative Success | Primary Male Monitoring | Abnormal Glands Patients |
Flow cytometric analysis of RNA content in different cell populations using pyronin Y and methyl green
[ PUBLICATION ]
Pyronin Y (PY) was used, in flow cytometric (FCM) systems, to estimate the RNA content per cell in formalin fixed EL4 leukosis tumor cells, enzyme dispersed R3327-G rat prostatic adenocarcinoma cells, mouse spleen cells stimulated with concanavalin A, and human peripheral blood lymphocytes stimulated with phytohemagglutinin. Preincubation of the cells with methyl green (MG) blocked PY binding to DNA such that the intracellular fluorescence from MG-PY was due primarily to its binding to ...
Known for Methyl Green | Rna Content | Cytometric Analysis | Cells Dna | Cell Populations |
OBJECTIVE: To decrease the operative time for parathyroidectomy in patients with hypercalcemic (primary) hyperparathyroid disease, a combination of preoperative localization of a parathyroid tumor with an effective nuclear scan (scintigram) and intraoperative monitoring of parathyroid hormone (quick parathyroid hormone measurement) to ensure excision of all hyperfunctioning tissue was studied.
SUMMARY BACKGROUND DATA: For many years, persistent hypercalcemia after parathyroidectomy (3% ...
Known for Parathyroidectomy Patients | Parathyroid Hormone | Operative Time | Hyperfunctioning Glands | Persistent Hypercalcemia |
Intraoperative parathyroid hormone (PTH) assay (QPTH) has made possible less invasive operative approaches in the treatment of primary hyperparathyroidism with stated advantages. When compared to the traditional bilateral neck exploration (BNE), only the targeted, hypersecreting gland is excised, leaving in situ non-visualized but normally functioning parathyroids. The QPTH-guided limited parathyroidectomy (LPX) must be able to identify multiglandular disease (MGD), predict a successful ...
Known for Intraoperative Parathyroid | Hormone Assay | Multiglandular Disease | 6 Months | Operative Failure |
Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies
[ PUBLICATION ]
BACKGROUND: Many patients with sporadic primary hyperparathyroidism (SPHPT) have discordant preoperative Tc-99m-sestamibi (MIBI) and ultrasonography studies prior to focused parathyroidectomy (PTX). This study examines the usefulness of intraoperative parathormone monitoring (IPM) during PTX in patients with discordant preoperative localization studies.
METHODS: A retrospective series of 225 consecutive SPHPT patients with MIBI scans and surgeon performed ultrasonography (SUS) prior to ...
Known for Localization Studies | Patients Ipm | Operative Success | Focused Parathyroidectomy | Imaging Radiopharmaceuticals |
Progress in the Operative Management of Sporadic Primary Hyperparathyroidism Over 34 Years
[ PUBLICATION ]
BACKGROUND: Progress in the diagnosis, localization of abnormal parathyroids, and intraoperative management of primary hyperparathyroidism has been observed over the past 34 years. The goal of this study is to report the outcome of patients undergoing 2 different operative approaches in a single institution, showing the evolution of surgical management of sporadic primary hyperparathyroidism (SPHPT).
METHODS: Parathyroidectomy was performed in 890 (827 initial, 63 reoperative) patients ...
Known for Operative Management | Primary Hyperparathyroidism | 6 Months | Lpx Bne | Calcium Female Humans |
BACKGROUND: There remains concern that focused parathyroidectomy guided by intra-operative parathormone monitoring (IPM) will miss multiglandular disease (MGD) leading to a higher recurrence rate. This study reports the 10-year outcome of patients with sporadic primary hyperparathyroidism treated by focused parathyroidectomy guided by IPM.
METHODS: From 1993 to 1998, 173 consecutive patients with sporadic primary hyperparathyroidism underwent focused parathyroidectomy guided by IPM. When ...
Known for Focused Parathyroidectomy | Multiglandular Disease | Sporadic Primary | Parathormone Monitoring | Recurrent Hyperparathyroidism |
With a secure diagnosis of hyperparathyroidism, preoperative localization of abnormal glands is the initial step toward limited parathyroidectomy (LPX). We investigated whether ultrasonography in the hands of the surgeon (SUS) could improve the localization of abnormal parathyroids when sestamibi scans (MIBI) were negative or equivocal. One hundred eighty patients with sporadic primary hyperparathyroidism (SPHPT) underwent preoperative SUS and MIBI scans before LPX guided by ...
Known for Sestamibi Scans | Preoperative Localization | Parathyroid Hormone | Mibi Patients | Abnormal Glands |
Biliary Tract Excretion of Cefazolin, Cephalothin, and Cephaloridine in the Presence of Biliary Tract Disease
[ PUBLICATION ]
The biliary tract excretion of three cephalosporins, cefazolin, cephaloridine, and cephalothin, was compared in patients with biliary tract disease. In the absence of obstruction, mean antibiotic levels in bile from gall bladder and common duct in patients undergoing cholecystectomy were highest for cefazolin (17 and 31 mug/ml, respectively) than either cephaloridine (7 and 9 mug/ml) or cephalothin (1 and 4 mug/ml). Biliary tract levels generally paralleled serum levels. In no patient ...
Known for Biliary Tract | Cefazolin Cephalothin | Peak Levels | Gall Bladder | Common Duct |
HYPOTHESIS: Untreated long-term elevated parathyroid hormone (PTH) levels after successful parathyroidectomy may predict recurrent hyperparathyroidism (HPT). Although elevated PTH levels have been reported in eucalcemic patients after parathyroidectomy for sporadic primary HPT, the long-term clinical significance of this finding remains unclear.
DESIGN: Retrospective case series.
SETTING: Tertiary referral center.
PATIENTS: Five hundred seventy-six consecutive patients with ...
Known for Successful Parathyroidectomy | Pth Levels | Parathyroid Hormone | Sporadic Primary | Patients Elevated |
Operative Failure in the Era of Focused Parathyroidectomy: A Contemporary Series of 845 Patients
[ PUBLICATION ]
HYPOTHESIS: Focused parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IPM) may lead to higher failure rates because of missed multiglandular disease.
DESIGN: Retrospective review of prospectively collected data.
SETTING: Tertiary referral center.
PATIENTS: From September 8, 1993, through January 30, 2009, a total of 845 consecutive patients with sporadic primary hyperparathyroidism underwent focused parathyroidectomy guided by IPM at a single institution.
MAIN ...
Known for Operative Failure | Focused Parathyroidectomy | 6 Months | Parathyroid Hormone | Retrospective Review |
OBJECTIVE: To evaluate whether the combined application of preoperative localization and intraoperative monitoring of intact parathyroid hormone (iPTH) levels could facilitate safe outpatient parathyroidectomy.
DESIGN: Consecutive patients, who had no antecedent social or medical conditions mandating hospitalization, were prospectively offered ambulatory parathyroidectomy with a mean follow-up of 7 months (range, 1-25 months).
SETTING: Tertiary care referral center
PATIENTS: From 85 ...
Known for Primary Hyperparathyroidism | Preoperative Localization | Ipth Levels | Successful Parathyroidectomy | Imaging Technetium |
Key People For Successful Parathyroidectomy
GEORGE LEE Irvin:Expert Impact
Concepts for whichGEORGE LEE Irvinhas direct influence:Successful parathyroidectomy, Limited parathyroidectomy, Primary hyperparathyroidism, Operative failure, Parathyroid hormone, Cytometric analysis, Normal range, Operative success.
GEORGE LEE Irvin:KOL impact
Concepts related to the work of other authors for whichfor which GEORGE LEE Irvin has influence:Primary hyperparathyroidism, Parathyroid hormone, Minimally invasive, Colorectal surgery, Preoperative localization, Flow cytometry, Bowel preparation.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |